Amphastar Pharmaceuticals, Inc.

XNASHealth care

Last traded price · USD

$28.02

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 05:05 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $28.02
Volume: —
Day's high: —
Day's low: —

In brief

Amphastar Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $1.19B.
Its shares closed at $28.02 on 4 Nov 2026, up 10.9% over the past year.
From India you can buy AMPH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Amphastar Pharmaceuticals, Inc. (AMPH) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole AMPH share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade AMPH options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +8.1% (SPY −1.6%, XLV +13.5%). 3 months: +38.4% (SPY −0.4%, XLV +15.5%). 1 year: +10.9% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: AMPH, SPY and XLV · as of 4 Nov 2026
9.8 days to cover short interest
4.3M shares were sold short at the 15 Oct 2026 settlement, 10.2% of the 42.5M shares outstanding; covering them would take 9.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
5.1% below its 52-week high
Closed at $28.02 on 4 Nov 2026: 5.1% below the 52-week high of $29.52 (12 Jan 2026) and 68.3% above the low of $16.65 (18 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $28.02 was 11.6% above its 50-day average ($25.11) and 25.8% above its 200-day average ($22.27). It has closed above the 200-day for 46 sessions, since 1 Sep 2026. The 50-day average crossed above the 200-day on 2 Oct 2026, 23 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.1%

6 months+17.2%

1 year+10.9%

5 years+41.8%

Newswire

About

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Website

Notable moves

May 8, 2026
−20.93%
February 27, 2026
−23.63%
June 9, 2022
−21.15%

Newswire

About

Website

Notable moves

May 8, 2026
−20.93%
February 27, 2026
−23.63%
June 9, 2022
−21.15%

Amphastar Pharmaceuticals, Inc.

XNASHealth care

Last traded price · USD

$28.02

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 05:05 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $28.02
Volume: —
Day's high: —
Day's low: —

In brief

Amphastar Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $1.19B.
Its shares closed at $28.02 on 4 Nov 2026, up 10.9% over the past year.
From India you can buy AMPH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Amphastar Pharmaceuticals, Inc. (AMPH) shares from India?

Do I need the price of a whole AMPH share to invest?

How much can I invest in US stocks in a year?

Can I trade AMPH options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +8.1% (SPY −1.6%, XLV +13.5%). 3 months: +38.4% (SPY −0.4%, XLV +15.5%). 1 year: +10.9% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: AMPH, SPY and XLV · as of 4 Nov 2026
9.8 days to cover short interest
4.3M shares were sold short at the 15 Oct 2026 settlement, 10.2% of the 42.5M shares outstanding; covering them would take 9.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
5.1% below its 52-week high
Closed at $28.02 on 4 Nov 2026: 5.1% below the 52-week high of $29.52 (12 Jan 2026) and 68.3% above the low of $16.65 (18 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $28.02 was 11.6% above its 50-day average ($25.11) and 25.8% above its 200-day average ($22.27). It has closed above the 200-day for 46 sessions, since 1 Sep 2026. The 50-day average crossed above the 200-day on 2 Oct 2026, 23 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+8.1%

6 months+17.2%

1 year+10.9%

5 years+41.8%

Newswire

About

Website

Notable moves

May 8, 2026
−20.93%
February 27, 2026
−23.63%
June 9, 2022
−21.15%

Newswire

About

Website

Notable moves

May 8, 2026
−20.93%
February 27, 2026
−23.63%
June 9, 2022
−21.15%

Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

9.8 days to cover short interest

5.1% below its 52-week high

Above its 50- and 200-day averages

Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

9.8 days to cover short interest

5.1% below its 52-week high

Above its 50- and 200-day averages